01884nas a2200313   4500000000100000008004100001260001300042653002500055653001000080653001100090653002100101653001100122653001200133653002400145653002500169653002500194653001600219653000900235100001300244700001500257700001900272700001100291245010500302856004100407300000900448490000700457520109200464022001401556       1991                            d  c1991 Mar10aAdministration, Oral10aAdult10aCopper10aErythema Nodosum10aHumans10aleprosy10aLeprosy, Borderline10aLeprosy, lepromatous10aLeprosy, Tuberculoid10aMiddle Aged10aZinc1 aGeorge J1 aBhatia V N1 aBalakrishnan S1 aRamu G00aSerum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.  uhttp://ila.ilsl.br/pdfs/v59n1a04.pdf  a20-40 v593 a<p>Serum zinc and copper levels and zinc/copper ratios were studied in 86 healthy controls, 45 cases of borderline tuberculoid (BT), 31 cases of borderline lepromatous (BL), 117 cases of lepromatous (LL) leprosy patients, 16 cases with severe erythema nodosum leprosum (ENL) reaction, and 16 cases with ENL reaction receiving oral zinc therapy. A significant reduction in serum zinc levels was noticed in all types of leprosy, the maximum decrease being seen in cases with ENL reaction. Conversely, the copper levels were significantly increased from BT to LL cases with ENL reaction in a progressive manner. A very good negative correlation (r = -0.998) was noticed between mean serum zinc and copper levels from healthy controls to active LL cases with ENL reaction. After oral zinc therapy, the serum zinc levels were significantly increased in all of the 16 LL patients with ENL reaction. In contrast, the copper levels were not decreased, indicating that oral zinc therapy can restore normal zinc levels in leprosy patients but is unable to reduce the increased copper levels.</p>
  a0148-916X